World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
51667
World Ranking
6158
National Ranking
599

Overview

Tim Meyer is affiliated with University College London in the United Kingdom. Their primary field of study is Medicine, with a significant focus on Oncology, Hepatology, Epidemiology, Pulmonary and Respiratory Medicine, and Immunology.

The scientist's research centers particularly on hepatocellular carcinoma, cancer immunotherapy, and liver disease. Specific main topics covered in their body of work include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Ferroptosis and cancer prognosis
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies

Tim Meyer's recent published papers include:

  • Hepatocellular carcinoma (2022), The Lancet
  • Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma (2020), Journal of Clinical Oncology
  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma (2021), Nature Reviews Gastroenterology & Hepatology
  • Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines (2021), Annals of Oncology
  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference (2020), Hepatology

Frequent co-authors with whom Meyer has collaborated include:

  • Richard S. Finn
  • Masatoshi Kudo
  • Josep M. Llovet
  • Arndt Vogel
  • Ann-Lii Cheng

The scientist's publications often appear in the following venues:

  • Journal of Clinical Oncology
  • Journal of Hepatology
  • Annals of Oncology
  • Liver Cancer
  • Clinical Cancer Research

Best Publications

  • Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

    Anthony B. El-Khoueiry;Bruno Sangro;Thomas Yau;Todd S. Crocenzi

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Straight sprinting is the most frequent action in goal situations in professional football

    Oliver Faude;Thorsten Koch;Tim Meyer

  • Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma

    Richard S. Finn;Masafumi Ikeda;Andrew X. Zhu;Max W. Sung

  • Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies

    Laura Marelli;Rosa Stigliano;Christos Triantos;Marco Senzolo

  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

    John K Ramage;A Ahmed;J Ardill;N Bax

  • Lactate threshold concepts: how valid are they?

    Oliver Faude;Wilfried Kindermann;Tim Meyer

  • Hippocampal Plasticity in Response to Exercise in Schizophrenia

    Frank-Gerald Pajonk;Thomas Wobrock;Oliver Gruber;Harald Scherk

  • Sleep and athletic performance: the effects of sleep loss on exercise performance, and physiological and cognitive responses to exercise.

    Hugh H. K. Fullagar;Sabrina Skorski;Rob Duffield;Daniel Hammes

  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Thierry De Baere;Thierry De Baere;Laura Kulik;Philipp K. Haber

  • A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability

    Manuel Rodríguez-Perálvarez;Tu Vinh Luong;Lorenzo Andreana;Tim Meyer

  • Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder

    Andreas Broocks;Borwin Bandelow;Gunda Pekrun;Annette George

  • Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

    Malte Tiburcy;James E. Hudson;Paul Balfanz;Susanne Schlick

  • A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters--theory and application.

    T Meyer;A Lucia;Conrad P Earnest;W Kindermann

  • Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.

    Tim Meyer;Tim Meyer;Richard Fox;Yuk Ting Ma;Paul J Ross;Paul J Ross

  • Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall

    Christian Werner;Tobias Fürster;Thomas Widmann;Janine Pöss

  • Role of tumour markers in monitoring epithelial ovarian cancer.

    T Meyer;G J S Rustin

  • Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.

    Giacomo Germani;Maria Pleguezuelo;Kurinchi Gurusamy;Tim Meyer

  • A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

    L. Kadalayil;R. Benini;L. Pallan;J. O'Beirne

Frequent Co-Authors

Michael Kellmann
Michael Kellmann Ruhr University Bochum
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Masatoshi Kudo
Masatoshi Kudo Kindai University
Bruno Sangro
Bruno Sangro University of Navarra
Juan W. Valle
Juan W. Valle University of Manchester
Josep M. Llovet
Josep M. Llovet University of Barcelona
Ann-Lii Cheng
Ann-Lii Cheng National Taiwan University
Philip J. Johnson
Philip J. Johnson University of Liverpool
Modesto Orozco
Modesto Orozco University of Barcelona
John A. Hartley
John A. Hartley University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing a traditional MD in the USA remains highly competitive, there are many alternative medical and healthcare career paths available through online degrees. For those interested in pharmacy, some universities now offer a 3 year online pharmd program, allowing students to earn their Doctor of Pharmacy in a flexible, accelerated format.

Other fields, such as healthcare data management, offer the opportunity to enroll in an online mhi (Master in Health Information Management). This degree prepares you for leadership roles in the fast-growing health informatics sector.

If you're looking for a quicker entry into healthcare, training in billing and coding is a cost-effective option. You can find details on medical billing and coding cost for online certificate and diploma programs.

For nurses aiming to expand their scope of practice, the cheapest online np programs can help you qualify as a nurse practitioner while balancing work and study.

Exploring these online programs can open new career opportunities in the healthcare field, with flexible learning and varying time commitments.

Best Scientists Citing Tim Meyer

Trending Scientists

Recently Published Articles